Search clinical trials for: calcium sensing receptor,
Total 24353 results
-
University of TromsoCompleted
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingStage IIIA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Breast AdenocarcinomaUnited States, Canada
-
Northwestern UniversityNational Cancer Institute (NCI); AmgenTerminatedStage IV Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Breast Carcinoma Metastatic in the Bone | Circulating Tumor Cell CountUnited States
-
Postgraduate Institute of Medical Education and...UnknownPrimary Hyperparathyroidism (PHPT)India
-
Tongji HospitalRecruitingBreast Cancer | TNBC - Triple-Negative Breast Cancer | Estrogen-receptor-negative Breast CancerChina
-
North Eastern German Society of Gynaecological...Center for Clinical Trials Philipps University MarburgActive, not recruitingEstrogen Receptor Positive Tumor | Primary Invasive Breast Cancer | Human Epidermal Growth Factor Receptor 2 Negative TumorGermany, Switzerland
-
Second Affiliated Hospital of Soochow UniversitySoochow T-Maximun Biotechnology Co. LTDRecruitingAdvanced Glioma | Complication of Chimeric Antigen Receptor (CAR-T) Cell TherapyChina
-
Gilead SciencesTerminatedAdvanced Estrogen Receptor Positive HER2- Breast CancerUnited States
-
Institut Català d'OncologiaAmgenActive, not recruitingStage I Breast Cancer | Breast Neoplasm Female | Stage II Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative NeoplasmSpain
-
MedSIRPfizerCompletedBreast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastSpain, Germany, France, United Kingdom, Italy, Slovenia
-
Turku University HospitalActive, not recruiting
-
University of WashingtonUniversity of Washington Institute for Translational Health Science (KL2)CompletedDiabetes Mellitus | Diabetic Kidney Disease | Chronic Kidney DiseaseUnited States
-
University Health Network, TorontoSuspendedLung Transplant RecipientCanada
-
Madigan Army Medical CenterTriService Nursing Research ProgramCompleted
-
Northwestern UniversityNational Cancer Institute (NCI)Not yet recruitingMetastatic Breast Cancer | Estrogen-receptor-positive Breast Cancer | HER2/Neu-Negative Breast Cancer | Advanced Breast CancervUnited States
-
University Hospital of FerraraRecruitingNeuroendocrine Tumors | Peptide Receptor Radionuclide Therapy (PRRT)Italy
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
ActelionCompletedHypertension, PulmonaryTaiwan, Korea, Republic of, Belarus, India, Romania, Ukraine
-
Baylor College of MedicineThe Methodist Hospital Research InstituteWithdrawnClassical Hodgkin Lymphoma | Extranodal Natural Killer/T-Cell Lymphoma, Nasal TypeUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedType 2 DiabetesChina
-
AmgenActavis Inc.CompletedBreast CancerItaly, Hungary, Russian Federation, South Africa, Spain, Serbia, Belarus, Ukraine, Chile, Germany, Bulgaria, Greece, Poland, Canada, Brazil, Mexico, Romania, United Kingdom
-
M.D. Anderson Cancer CenterTerminatedBlood Stem Cell Transplant Failure | Disorder Related to Bone Marrow Transplantation | Transmission, Blood, Recipient/Donor | Disturbance of Emotions Specific to Childhood and Adolescence | SiblingUnited States
-
Shanghai Jiao Tong University School of MedicineCompletedLiver Transplantation | Transplant RecipientChina
-
Kessler FoundationHackensack Meridian HealthRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Baylor College of MedicineThe Methodist Hospital Research InstituteRecruitingClassical Hodgkin Lymphoma | Extranodal Natural Killer/T-Cell Lymphoma, Nasal TypeUnited States
-
Margaret RagniWyeth is now a wholly owned subsidiary of Pfizer; University of North CarolinaTerminated
-
CSL BehringCompleted
-
Duke UniversityBaylor College of Medicine; Yale University; Icahn School of Medicine at Mount... and other collaboratorsCompletedANXIETY DISORDERS (or Anxiety and Phobic Neuroses)United States
-
Tianjin Medical University Second HospitalRecruitingMalignant Pleural Mesothelioma, AdvancedChina
-
Eisai Inc.Completed
-
Mayo ClinicCompletedKidney Transplant Recipient | Blood Pressure ControlUnited States
-
Centre Hospitalier Universitaire de NiceCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | MLH1 Gene Mutation | RAD51C Gene Mutation | RAD51D Gene Mutation | BRIP1 Gene Mutation | PALB2 Gene Mutation | BARD1 Gene Mutation | MSH2 Gene Mutation | MSH6... and other conditionsUnited States
-
Helwan UniversityNot yet recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone-receptor-positive Breast Cancer
-
University Hospital, BordeauxCompletedCardiac Surgery | Cardiopulmonary Bypass | Renal Transplant RecipientFrance
-
University of ArizonaNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor Positive TumorUnited States
-
Fengxi SuUnknownBreast Cancer Patients in Premenopausal | Estrogen and/or Progesterone Receptor PositiveChina
-
University of EdinburghBritish Heart FoundationCompletedProteinuria | Chronic Kidney DiseaseUnited Kingdom
-
BeiGeneRecruitingBreast Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Hormone Receptor Positive Malignant Neoplasm of Breast | HER2-negative Breast Cancer | Hormone-receptor-positive Breast CancerChina
-
AmgenRecruitingSolid TumorsCanada, Korea, Republic of, Australia, Netherlands, United States, Israel, Austria, Spain, United Kingdom, France, Belgium, Japan, Czechia, Hungary, Poland, Brazil, Argentina, Denmark, Greece, Mexico, Switzerland, Romania, Italy, Finland and more
-
University of Wisconsin, MadisonNot yet recruitingNeuroendocrine Tumors | Somatostatin Receptor-positive Neuroendocrine TumorUnited States
-
National Cancer Institute (NCI)TerminatedUterine Cervical NeoplasmsUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, India, Slovakia, Spain, United Kingdom, Finland, Ireland, Germany, Greece, Puerto Rico, Romania, Bulgaria, Latvia, Hong Kong, Lithuania, Portugal
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany, Hungary
-
University Hospital Birmingham NHS Foundation TrustUniversity of Birmingham; National Institute for Health Research, United Kingdom and other collaboratorsUnknownVitamin D Deficiency | Crohn DiseaseUnited Kingdom
-
University of Turin, ItalyCompletedVitamin D Deficiency | Asthma | Disease Exacerbation
-
Toni Choueiri, MDWithdrawnAdenocarcinoma of the ProstateUnited States
-
National Cancer Institute (NCI)GlaxoSmithKlineCompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Invasive Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
Aragon Pharmaceuticals, Inc.Completed